Search

Search Constraints

You searched for: Author/Creator Ricard, Ingrid

Search Results

1. Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. Issue 8 (August 2019)

3. Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110). (April 2021)

4. Relevance of liver‐limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE‐3/AIO KRK0306 trial. Issue 5 (7th November 2017)

5. Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial. Issue 100 (March 2018)

6. Predictors of cerebrovascular events at mid-term after transcatheter aortic valve implantation – Results from EVERY-TAVI registry. (1st October 2017)

7. Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive Aphasia. (7th January 2022)

8. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase III trial FIRE‐3 (AIO KRK‐0306). Issue 1 (6th September 2021)

10. Methylated free‐circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer. Issue 9 (22nd February 2017)